More recently, Jean-Michel was with Eli-Lilly acting as Vice-President, North American Oncology, as well as Managing Director Northern Europe (including the UK and Ireland). Externally, Jean-Michel represented Lilly in the CEO Forum in Washington DC, was a board member of the ABPI and the Chairman of the Board of the American Pharmaceutical Group.
Jean-Michel holds an MBA from the Rotterdam School of Management (Erasmus University), The Netherlands. He received his PhD with honours in Nuclear Chemistry and Neurobiology from University Paris, France, and conducted post-doctoral research in Neuropharmacology at the NIH in the United States. Additionally, he holds a Pharm D with honours in Pharmacology from the University of Paris.